U.S. FDA Suggests Multi-layered Approach To Combat Counterfeit Drugs
This article was originally published in PharmAsia News
Executive Summary
SEOUL - U.S. FDA is encouraging regulatory counterparts in Asia Pacific Economic Cooperation forum countries to adopt a multi-layered approach to combat counterfeit drugs
You may also be interested in...
Would New Drug Launches Speed Up With A Pan-Asia Regulatory Framework? - Biopharma Asia Conference
SINGAPORE - As diseases like diabetes and cardiovascular complications - previously believed to be more prevalent in Western nations - are progressively spreading East to places like India and China, Asia-based pharmaceutical companies are pushing for a pan-Asian regulatory regime that can benefit its people with clear and obtainable goals
Would New Drug Launches Speed Up With A Pan-Asia Regulatory Framework? - Biopharma Asia Conference
SINGAPORE - As diseases like diabetes and cardiovascular complications - previously believed to be more prevalent in Western nations - are progressively spreading East to places like India and China, Asia-based pharmaceutical companies are pushing for a pan-Asian regulatory regime that can benefit its people with clear and obtainable goals
Korea and Singapore Regulators Sign Trade MOU For Drugs, Devices
SEOUL - Korea's FDA and Singapore's Health Sciences Authority have signed a memorandum of understanding as part of their efforts to ensure the safety, quality and efficacy of health products traded between the two countries